Formulations of alpha-amylase inhibitors with alpha-glucosidase inhibitors useful in the treatment of diabetes and obesity
    5.
    发明授权
    Formulations of alpha-amylase inhibitors with alpha-glucosidase inhibitors useful in the treatment of diabetes and obesity 有权
    用于治疗糖尿病和肥胖症的α-葡糖苷酶抑制剂的α-淀粉酶抑制剂的制剂

    公开(公告)号:US07553502B2

    公开(公告)日:2009-06-30

    申请号:US12042355

    申请日:2008-03-05

    IPC分类号: A01N65/00

    摘要: This invention relates to the combination of α-amylase inhibitors prepared from Phaseolus vulgaris with α-glucosidase inhibitors obtained from Salacia oblonga and other species. The α-amylase inhibitor is accompanied by a quantity of lectins that reduces the amount of glucose originating from the starches present in the diet, and considerably reduces the appetite after repeated administration. The combination with α-glucosidase inhibitors, such as extracts of Salacia or the thiosugars present in it, further reduce the blood glucose, acting synergically, and consequently reduce the synthesis of fats from carbohydrates.

    摘要翻译: 本发明涉及从菜豆提取物制备的α-淀粉酶抑制剂与从长颈鹿藻和其他物种获得的α-葡糖苷酶抑制剂的组合。 α-淀粉酶抑制剂伴随着一定量的凝集素,其降低源自饮食中存在的淀粉的葡萄糖的量,并且在重复给药后显着降低食欲。 与α-葡萄糖苷酶抑制剂(如Salacia提取物或其中存在的硫代糖)的组合进一步降低血糖,协同作用,从而减少碳水化合物的脂肪合成。

    FORMULATIONS OF ALPHA-AMYLASE INHIBITORS WITH ALPHA-GLUCOSIDASE INNHIBITORS USEFUL IN THE TREATMENT OF DIABETES AND OBESITY
    6.
    发明申请
    FORMULATIONS OF ALPHA-AMYLASE INHIBITORS WITH ALPHA-GLUCOSIDASE INNHIBITORS USEFUL IN THE TREATMENT OF DIABETES AND OBESITY 有权
    用于治疗糖尿病和肥胖症的ALPHA-葡萄糖苷酶抑制剂的阿尔法 - 淀粉酶抑制剂的配方

    公开(公告)号:US20080220098A1

    公开(公告)日:2008-09-11

    申请号:US12042355

    申请日:2008-03-05

    IPC分类号: A61K36/00 A61K38/16

    摘要: This invention relates to the combination of α-amylase inhibitors prepared from Phaseolus vulgaris with α-glucosidase inhibitors obtained from Salacia oblonga and other species. The α-amylase inhibitor is accompanied by a quantity of lectins that reduces the amount of glucose originating from the starches present in the diet, and considerably reduces the appetite after repeated administration. The combination with α-glucosidase inhibitors, such as extracts of Salacia or the thiosugars present in it, further reduce the blood glucose, acting synergically, and consequently reduce the synthesis of fats from carbohydrates.

    摘要翻译: 本发明涉及从菜豆提取物制备的α-淀粉酶抑制剂与从长颈鹿藻和其他物种获得的α-葡糖苷酶抑制剂的组合。 α-淀粉酶抑制剂伴随着一定量的凝集素,其降低源自饮食中存在的淀粉的葡萄糖的量,并且在重复给药后显着降低食欲。 与α-葡萄糖苷酶抑制剂(如Salacia提取物或其中存在的硫代糖)的组合进一步降低血糖,协同作用,从而减少碳水化合物的脂肪合成。

    Process for the biotransformation of colchicone compounds into the correspondence 3-glycosyl derivatives
    7.
    发明授权
    Process for the biotransformation of colchicone compounds into the correspondence 3-glycosyl derivatives 有权
    将秋水仙碱化合物生物转化成对应的3-糖基衍生物的方法

    公开(公告)号:US06372458B1

    公开(公告)日:2002-04-16

    申请号:US09539867

    申请日:2000-03-31

    IPC分类号: C12P1944

    CPC分类号: C12P19/56

    摘要: The present invention relates to the microbial biotransformation of colchiconic compounds into derivative compounds, which are glycosylated exclusively at the C-3 position of the six-member ring. The process of the present invention provides the 3-O-glycosyl derivatives in high yields and purity.

    摘要翻译: 本发明涉及可可丝素化合物微生物转化为衍生化合物,其仅在六元环的C-3位糖基化。 本发明的方法以高产率和纯度提供了3-O-糖基衍生物。